# Lipiodol marking for CT-guided radiofrequency ablation of adrenal aldosterone-producing adenomas: a case series

**Authors:** Hiromitsu Tannai, Sota Oguro, Hiroyuki Sakakibara, Yumi Nakajima, Hiroki Kamada, Yuta Tezuka, Yoshikiyo Ono, Hideki Ota, Kei Takase

PMC · DOI: 10.1186/s42155-025-00614-2 · CVIR Endovascular · 2025-10-28

## TL;DR

This case series shows how using Lipiodol during CT-guided radiofrequency ablation improves visibility of adrenal tumors, helping treat hormone-producing adenomas effectively.

## Contribution

The study introduces Lipiodol marking as a novel technique to enhance lesion visibility during adrenal RFA procedures.

## Key findings

- Lipiodol marking significantly improved nodule visibility during RFA in three out of four cases.
- RFA completed without major complications led to resolution of primary aldosteronism and hypertension.
- Extravasation during embolization occurred in one case but did not prevent successful RFA the next day.

## Abstract

Tumor visualization during computed tomography (CT)-guided radiofrequency ablation (RFA) of adrenal adenomas is often limited by the small size of the lesion and needle-induced artifacts. These limitations can impair accurate needle placement and increase the risk of incomplete ablation. This report shows four adrenal RFA procedures in which iodized oil (Lipiodol®) marking enhanced lesion visibility.

CT imaging and adrenal venous sampling showed unilateral right aldosterone-producing adenomas measuring 10–20 mm in patients with primary aldosteronism. Contrast enhancement of the nodules was confirmed via CT angiography after microcatheter insertion into the adrenal artery. Transarterial embolization was performed utilizing a 1:1 mixture of Lipiodol and iohexol. In three cases, Lipiodol deposition within the adenomas was confirmed on CT immediately post-embolization and persisted on the following day. Despite needle-induced artifacts during RFA, nodule visibility significantly improved. RFA was completed without major complications, which resulted in the resolution of primary aldosteronism and hypertension. In one case, although Lipiodol marking was discontinued due to the extravasation from the adrenal artery branch, RFA was completed on the following day.

CT-guided RFA with Lipiodol marking facilitated the effective treatment of aldosterone-producing adrenal adenomas in three patients by significantly enhancing lesion visibility. Adrenal arterial embolization should be addressed with caution to avoid damaging the small blood vessels of the adrenal gland.

The online version contains supplementary material available at 10.1186/s42155-025-00614-2.

## Linked entities

- **Chemicals:** iohexol (PubChem CID 3730)
- **Diseases:** primary aldosteronism (MONDO:0001422)

## Full-text entities

- **Diseases:** hypertension (MESH:D006973), aldosterone-producing adenomas (MESH:D006929), aldosterone-producing adrenal adenomas (MESH:D001477), Tumor (MESH:D009369), adrenal adenomas (MESH:D018246), primary aldosteronism (OMIM:617027), adenomas (MESH:D000236)
- **Chemicals:** Lipiodol (MESH:D004998), iodized oil (MESH:D007459), iohexol (MESH:D007472)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12569250/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12569250/full.md

---
Source: https://tomesphere.com/paper/PMC12569250